Resources

Resources

    20Resources found...

  • Publication

    Effect of point-of-care early infant diagnosis on antiretroviral therapy initiation and retention of patients: a cluster-randomised trial

    In this cluster-randomized controlled trial, Jani et al. evaluated the effect of point-of-care (POC) early infant HIV testing on rates of antiretroviral therapy (ART) initiation and retention in care among HIV-positive infants who presented for early infant diagnosis at health facilities in Mozambique. POC achieved more rapidly diagnosis and timely provision of treatment to HIV-infected infants.

     Author(s) Jani et al   Originally published on April 18, 2019   Posted on October 12, 2018


  • Blog Article

    Innovative diagnostic technology can save HIV-positive infants

    A real life story of how of POC EID devices strategically placed at the point where they are direly needed testing for HIV exposed infants in Malawi, are great impact for the infants and their families. Infants born to or breastfed by HIV positive mothers are in need of timely HIV because risk of mortality is highest in the first weeks to months of life . Nearly half of the babies. In 2017, only 51 percent of all HIV-exposed infants were tested for HIV within the recommended first two months of life and only 52 percent of children living with HIV received life-saving ART. For details read full story here.

     Author(s) CHAI   Originally published on September 10, 2018   Posted on October 12, 2018


  • White Paper

    Point-of-care testing as a solution for timely early infant diagnosis

    Based on the recent encouraging evidence POC/ near-POC EID warrants  consideration of rapid adoption and strategic scale up of this solution complementing the existing laboratory network. Ravikiran Bhairavabhotla from CDC briefly outlines the  evidence and tools to support the strategic introduction of POC EID as part of a tiered national laboratory network.

     Author(s) Ravikiran Bhairavabhotla   Originally published on April 18, 2019   Posted on October 12, 2018


  • Publication

    A Proposed Framework for the Implementation of Early Infant Diagnosis Point-of-Care

    To reduce morbidity and mortality among HIV-infected children and close the treatment gap for HIV-infected children, there is an urgent need to evaluate existing programmatic and laboratory practices for early infant diagnosis and introduce strategies to improve identification of HIV-exposed infants and ensure access to systematic, early HIV testing, with early linkage to treatment for HIV-infected infants. This article describes progress made in follow-up of HIV-exposed infants since 2006, including remaining unmet laboratory and programmatic needs, and recommends strategies for improvement, especially those related to the implementation of point-of-care technology for early infant diagnosis.

     Author(s) Diallo et al   Originally published on January 1, 2017   Posted on October 12, 2018


  • Guidelines

    Early detection of HIV infection in infants and children

    Because of the high risk of death before the age of 2 years among HIV-infected infants, and given
    the increasing availability of paediatric antiretroviral treatment in many resource-limited settings,
    WHO recommends that national programmes should establish the capacity to provide early
    virological testing of infants for HIV.

     Author(s) WHO   Originally published on April 18, 2019   Posted on October 12, 2018


  • Guidelines

    WHO Information Note: NOVEL POINT-OF-CARE TOOLS FOR EARLY INFANT DIAGNOSIS OF HIV

    Novel point-of-care tools for early infant diagnosis of HIV WHO, 2017

    Sufficient evidence has been generated on the performance of these assays in the intended field settings to support rapid national regulatory approval and initiation of scale-up. Performance was consistent between laboratory and field settings, and across countries. Further technical evaluations of these technologies are unlikely to add value, but may instead delay implementation and timely diagnoses of HIV-infected infants, a critical and vulnerable population. National regulatory agencies are encouraged to not delay adoption by conducting further evaluations, but instead adopt a rapid and streamlined registration and national approval process for immediate implementation.

     Author(s) WHO   Originally published on January 1, 2017   Posted on October 12, 2018


Filter by ticking the boxes below and then click apply


projects

  • SLIPTA
  • APHLN
  • LabCoP
  • Point-of-Care
  • Laboratory Mapping
  • Other

resource type

  • Publication
  • Report
  • Guidelines
  • White Paper
  • Blog Article
  • Other

health topics

  • Antimicrobial Resistance
  • Biosafety/Biosecurity
  • Diagnostic Technology
  • Emerging Infectious Diseases
  • HIV/AIDS
  • HIV Co-infections
  • Maternal & Child Health
  • Other
  • Hepatitis B
  • Hepatitis C
  • Syphilis
  • Tuberculosis
  • Ebola
  • Viral Load Scale-Up